Melanoma · San Jose

Melanoma clinical trials in San Jose

2 recruiting melanoma studies within range of San Jose. Click any trial for full eligibility criteria and contact info.

IMC-F106C Regimen Versus Nivolumab Regimens in Previously Untreated Advanced Melanoma (PRISM-MEL-301)

NCT06112314 · Advanced Melanoma

Recruiting

This is a phase 3, randomized, controlled study of brenetafusp (IMC-F106C) plus nivolumab compared to standard nivolumab regimens in HLA-A\*02:01-positive participants with previously untreated advanced melanoma.

PhasePhase 3

TypeInterventional

Age18 Years

WhereTucson, Arizona, United States + 210 more

SponsorImmunocore Ltd

▾Tap for detailsClick for full details — eligibility, all locations, contacts

211 sitesApply

Apply Open full pageClinicalTrials.gov ↗

Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics

NCT06418204 · Breast Carcinoma, Colorectal Carcinoma, Lung Non-Small Cell Carcinoma

Recruiting

This is a multi-site clinical study enrolling 2000 newly diagnosed patients with breast, colorectal, melanoma, non-Hodgkin lymphoma, or non-small cell lung cancer, who are planning to receive one or more systemic cancer directed therapies with chemotherapy and/or (immune checkpoint inhibitors) ICIs.

Phase—

TypeObservational

Age18 Years

WhereFairbanks, Alaska, United States + 466 more

SponsorWake Forest University Health Sciences

▾Tap for detailsClick for full details — eligibility, all locations, contacts

467 sitesApply

Apply Open full pageClinicalTrials.gov ↗

← All melanoma trials (nationwide)